Metalloproteinase inhibition protects against reductions in circulating adrenomedullin during lead-induced acute hypertension


Autoria(s): Nascimento, Regina Aparecida do; Mendes, Gabryella; Possomato-Vieira, José Sérgio; Gonçalves-Rizzi, Victor Hugo; Kushima, Hélio; Delella, Flavia Karina; Dias-Junior, Carlos Alan
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

21/10/2015

21/10/2015

01/06/2015

Resumo

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Processo FAPESP: 2013/21.305-1

Intoxication with lead (Pb) results in increased blood pressure by mechanisms involving matrix metalloproteinases (MMPs). Recent findings have revealed that MMP type two (MMP-2) seems to cleave vasoactive peptides. This study examined whether MMP-2 and MMP-9 levels/activities increase after acute intoxication with low lead concentrations and whether these changes were associated with increases in blood pressure and circulating endothelin-1 or with reductions in circulating adrenomedullin and calcitonin gene-related peptide (CGRP). Here, we expand previous findings and examine whether doxycycline (a MMPs inhibitor) affects these alterations. Wistar rats received intraperitoneally (i.p.) 1st dose 8g/100g of lead (or sodium) acetate, a subsequent dose of 0.1g/100g to cover daily loss and treatment with doxycycline (30mg/kg/day) or water by gavage for 7days. Similar whole-blood lead levels (9g/dL) were found in lead-exposed rats treated with either doxycycline or water. Lead-induced increases in systolic blood pressure (from 143 +/- 2 to 167 +/- 3mmHg) and gelatin zymography of plasma samples showed that lead increased MMP-9 (but not MMP-2) levels. Both lead-induced increased MMP-9 activity and hypertension were blunted by doxycycline. Doxycycline also prevented lead-induced reductions in circulating adrenomedullin. No significant changes in plasma levels of endothelin-1 or CGRP were found. Lead-induced decreases in nitric oxide markers and antioxidant status were not prevented by doxycycline. In conclusion, acute lead exposure increases blood pressure and MMP-9 activity, which were blunted by doxycycline. These findings suggest that MMP-9 may contribute with lead-induced hypertension by cleaving the vasodilatory peptide adrenomedullin, thereby inhibiting adrenomedullin-dependent lowering of blood pressure.

Formato

508-515

Identificador

http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12337/abstract

Basic & Clinical Pharmacology & Toxicology. Hoboken: Wiley-blackwell, v. 116, n. 6, p. 508-515, 2015.

1742-7835

http://hdl.handle.net/11449/128574

http://dx.doi.org/10.1111/bcpt.12337

WOS:000354246100010

Idioma(s)

eng

Publicador

Wiley-Blackwell

Relação

Basic & Clinical Pharmacology & Toxicology

Direitos

closedAccess

Tipo

info:eu-repo/semantics/article